EP3277286
GALLSÝRUÚREFNI SEM FXR/TGR5 ÖRVAR OG AÐFERÐIR VIÐ NOTKUN ÞESS
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.3.2016EP published:
21.4.2021EP application number:
16774118.0
EP translation filed:
2.7.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
29.3.2036Expiry date:
29.3.2024
Title:
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
Timeline
Today
30.3.2016EP application
21.4.2021EP Publication
2.7.2021Translation submitted
15.7.2021Registration published
29.3.2024Expires
Owner
Name:
Enanta Pharmaceuticals, Inc.Address:
500 Arsenal Street, Watertown, MA 02472, US
Inventor
Name:
WANG, GuoqiangAddress:
Belmont, MA 02478, US
Name:
OR, Yat SunAddress:
Watertown, MA 02472, US
Name:
SHEN, RuichaoAddress:
Belmont, MA 02478, US
Name:
XING, XuechaoAddress:
Wilmington, MA 01887, US
Name:
LONG, JiangAddress:
Wayland, MA 01778, US
Name:
DAI, PengAddress:
Auburndale, MA 02466, US
Name:
GRANGER, BrettAddress:
Sudbury, MA 01776, US
Name:
HE, JingAddress:
Somerville, MA 02143, US
Agent
Name:
COSMOVICI INTELLECTUAL PROPERTY SARLAddress:
11 Boulevard Sébastopol, FR
Priority
Number:
201562140927 PDate:
31.3.2015Country:
US
Number:
201662287267 PDate:
26.1.2016Country:
US
Classification
Categories:
C07J 41/00, C07J 43/00, A61K 31/575, A61P 1/16, C07J 9/00, C07J 51/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.2.2022
Expires: 29.3.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.3.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.